MarketCap
Facebook
X
TelegramGeschäftsbericht 2022
hinzugefügt 20.03.2023
Athenex ROE 2011-2026 | ATNX
ROE Jährlich Athenex
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1589.72 | -390.7 | -88.41 | -70.37 | -91.2 | -144.58 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1589.72 | -390.7 | 134.08 |
ROE Vierteljährlich Athenex
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 426.14 | 399.6 | 452.23 | -159.66 | -64.8 | -92.33 | -86.27 | -88.39 | -81.31 | -65.32 | -63.32 | -57.83 | -65.75 | -73.66 | -88.32 | -97.76 | -84.27 | -96.23 | -88.95 | -105.4 | -145.68 | -232.75 | -279.73 | -273.57 | -228.05 | -109.57 | -36.74 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 452.23 | -279.73 | -55.1 |
ROE anderer Aktien in der Arzneimittelhersteller
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
431.6 | - | - | $ 754 M |  USA |
 |
Agile Therapeutics
AGRX
|
88.64 | - | 10.11 % | $ 58.2 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-66.13 | - | 0.12 % | $ 2.06 B |  France |
 |
Alimera Sciences
ALIM
|
-43.6 | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3276.74 | - | 0.86 % | $ 117 M | USA |
 |
Canopy Growth Corporation
CGC
|
-122.76 | - | -3.21 % | $ 114 M |  Canada |
 |
Cronos Group
CRON
|
-4.28 | - | -1.32 % | $ 1.35 B | Canada |
 |
Catalent
CTLT
|
-28.94 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
15.26 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
37.13 | - | - | $ 28.9 M |  Irlanda |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.33 | - | 1.17 % | $ 55 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-50.54 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-98.17 | - | 2.45 % | $ 38.1 M | Canada |
 |
Evoke Pharma
EVOK
|
302.08 | - | - | $ 36.6 M | USA |
 |
DURECT Corporation
DRRX
|
-186.86 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
-117.13 | $ 11.07 | - | $ 567 M | USA |
 |
Jupiter Wellness
JUPW
|
2273.74 | - | - | $ 33.6 M | USA |
 |
Evolus
EOLS
|
-913.07 | $ 4.35 | - | $ 270 M | USA |
 |
China Pharma Holdings
CPHI
|
-61.13 | - | -2.39 % | $ 11.4 M |  China |
 |
Harrow Health
HROW
|
-34.5 | $ 49.44 | 3.63 % | $ 1.61 B | USA |
 |
Pacira BioSciences
PCRX
|
-12.79 | $ 21.69 | 2.05 % | $ 1 B | USA |
 |
Perrigo Company plc
PRGO
|
-3.98 | $ 14.49 | 0.59 % | $ 1.99 B | USA |
 |
OrganiGram Holdings
OGI
|
-45.46 | $ 1.33 | - | $ 402 M | Canada |
 |
Lannett Company
LCI
|
92.26 | - | 1.15 % | $ 7.11 M | USA |
 |
Bausch Health Companies
BHC
|
57.93 | - | - | $ 2.22 B | Canada |
 |
Sundial Growers
SNDL
|
-88.87 | $ 1.51 | 1.01 % | $ 3.37 M | Canada |
 |
Tilray
TLRY
|
-43.81 | $ 7.54 | - | $ 4.66 B | Canada |
 |
Neoleukin Therapeutics
NLTX
|
7.34 | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
0.33 | - | -2.73 % | $ 492 M | USA |
 |
cbdMD
YCBD
|
-7.78 | $ 0.75 | -6.86 % | $ 3.23 M | USA |
 |
PetIQ
PETQ
|
0.96 | - | 1.64 % | $ 400 M | USA |
 |
Aurora Cannabis
ACB
|
-154.42 | - | -3.23 % | $ 86.3 M | Canada |
 |
ProPhase Labs
PRPH
|
29.02 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
27.81 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-22.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
-39.64 | $ 1.08 | -1.38 % | $ 25.2 M | USA |
 |
Relmada Therapeutics
RLMD
|
-115.74 | - | - | $ 120 M | USA |
 |
OptiNose
OPTN
|
40.97 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-240.53 | - | 2.31 % | $ 849 M | USA |
 |
PLx Pharma
PLXP
|
-129.32 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-78.37 | - | - | $ 3.52 M | USA |
 |
Solid Biosciences
SLDB
|
-90.86 | - | - | $ 261 M | USA |
 |
SCYNEXIS
SCYX
|
91.88 | $ 0.81 | - | $ 38.8 M | USA |
 |
Veru
VERU
|
-116.97 | - | 3.03 % | $ 321 M | USA |
 |
Tricida
TCDA
|
-80993.58 | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
-35.09 | $ 2.32 | -2.52 % | $ 24.2 M | USA |
 |
Viatris
VTRS
|
9.86 | - | - | $ 19.4 B | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-162.53 | - | 7.5 % | $ 6.35 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-75.79 | - | - | $ 55.5 M | USA |